Bayer | BAYN - Cost Of Sales

Stock Price
42.01
Daily Change
0.17 0.39%
Monthly
-7.04%
Yearly
84.98%
Q1 Forecast
42.20

Bayer reported EUR4.31B in Cost of Sales for its fiscal quarter ending in September of 2025.





Cost Of Sales Change Date
Air Liquide EUR 5.9B 415.5M Dec/2025
Akzo Nobel EUR 1.44B 84M Dec/2025
Alcon AG USD 1.16B 52M Sep/2025
Amarin USD 16.89M 18.51M Mar/2025
Arkema EUR 1.79B 12M Dec/2025
AstraZeneca USD 3.27B 471M Dec/2025
BASF EUR 10.93B 241M Dec/2025
Bayer EUR 4.31B 57M Sep/2025
Beiersdorf EUR 2.11B 130M Jun/2025
Corteva USD 2.41B 607M Dec/2025
Covestro EUR -2.68B 5.51B Sep/2025
Essilor EUR 6.06B 741M Dec/2025
Fresenius EUR 4.45B 262M Dec/2025
Fresenius Medical Care EUR 3.68B 38.37M Dec/2025
Genmab DKK 57M 15M Jun/2025
Givaudan CHF 1.05B 936.5M Jun/2024
GlaxoSmithKline GBP 2.61B 377M Dec/2025
GRIFOLS EUR 1.13B 15.63M Sep/2025
Henkel EUR 5.07B 260M Jun/2025
Hikma Pharmaceutical USD 466.5M 428.5M Jun/2025
Johnson Matthey GBP 5.04B 513M Dec/2025
Linde USD 4.38B 73M Sep/2025
Lonza CHF 2.28B 189M Jun/2025
Merck EUR 2.1B 123M Sep/2025
Novartis USD 3.54B 217M Sep/2025
Nutrien USD 3.45B 591M Dec/2025
Philips EUR 2.81B 417M Dec/2025
PPG Industries USD 2.45B 24M Dec/2025
Roche Holding CHF 8.48B 4.61B Dec/2025
Sanofi EUR 4.29B 421M Dec/2025
SAP EUR 2.56B 1.49B Dec/2025
Solvay EUR 860M 71M Dec/2025
UCB EUR 901M 50M Dec/2024
Umicore EUR 8.22B 4.83B Jun/2025
Vinci EUR 9.07B 632M Jun/2025